Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47

SIMPLE SUMMARY: Ovarian cancer is one of the most fatal gynecological malignancies in women. Even though primary treatment might result in complete remission, approximately 60–80% patients with advanced-stage ovarian cancer experience a relapse. To improve their survival outcomes, several novel agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yong-Jae, Nam, Eun-Ji, Kim, Sunghoon, Kim, Young-Tae, Itkin-Ansari, Pamela, Kim, Sang-Wun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221321/
https://www.ncbi.nlm.nih.gov/pubmed/35740568
http://dx.doi.org/10.3390/cancers14122903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221321/
https://www.ncbi.nlm.nih.gov/pubmed/35740568
http://dx.doi.org/10.3390/cancers14122903

Ejemplares similares